Yasutaka Igari

701 total citations
19 papers, 603 citations indexed

About

Yasutaka Igari is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Yasutaka Igari has authored 19 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in Yasutaka Igari's work include Drug Transport and Resistance Mechanisms (5 papers), Drug Solubulity and Delivery Systems (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Yasutaka Igari is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Drug Solubulity and Delivery Systems (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Yasutaka Igari collaborates with scholars based in Japan and United States. Yasutaka Igari's co-authors include Yuichi Sugiyama, Manabu Hanano, Yasufumi Sawada, Tatsuji Iga, Tsugio Shimamoto, Hajime Toguchi, Yasuaki Ogawa, Shoji Awazu, Toshihiro Shimizu and Yoshinori Nakano and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Controlled Release and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Yasutaka Igari

19 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasutaka Igari Japan 14 177 152 146 143 100 19 603
Nobutoshi Watari Japan 14 100 0.6× 105 0.7× 156 1.1× 101 0.7× 29 0.3× 36 516
Masayuki Akimoto Japan 12 122 0.7× 129 0.8× 169 1.2× 94 0.7× 71 0.7× 39 490
Guofei Li China 17 74 0.4× 186 1.2× 95 0.7× 84 0.6× 110 1.1× 46 627
Mark Wirth United States 9 59 0.3× 190 1.3× 125 0.9× 124 0.9× 75 0.8× 9 663
Yutaka Higashi Japan 16 70 0.4× 151 1.0× 268 1.8× 122 0.9× 36 0.4× 39 620
Eleftheria Tsakalozou United States 17 76 0.4× 212 1.4× 269 1.8× 168 1.2× 63 0.6× 47 763
Sumihisa Kimura Japan 11 195 1.1× 117 0.8× 75 0.5× 222 1.6× 18 0.2× 13 547
Yoshikazu Takeuchi Japan 16 50 0.3× 147 1.0× 83 0.6× 124 0.9× 33 0.3× 48 619
Graham Somers United Kingdom 13 93 0.5× 108 0.7× 68 0.5× 67 0.5× 23 0.2× 17 545
B.D. Rush United States 12 115 0.6× 145 1.0× 242 1.7× 113 0.8× 38 0.4× 23 698

Countries citing papers authored by Yasutaka Igari

Since Specialization
Citations

This map shows the geographic impact of Yasutaka Igari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasutaka Igari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasutaka Igari more than expected).

Fields of papers citing papers by Yasutaka Igari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasutaka Igari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasutaka Igari. The network helps show where Yasutaka Igari may publish in the future.

Co-authorship network of co-authors of Yasutaka Igari

This figure shows the co-authorship network connecting the top 25 collaborators of Yasutaka Igari. A scholar is included among the top collaborators of Yasutaka Igari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasutaka Igari. Yasutaka Igari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Aragane, Katsumi, et al.. (2014). Anti-counterfeit Activities of Pharmaceutical Companies in Japan: For Patient Safety. YAKUGAKU ZASSHI. 134(2). 203–211. 2 indexed citations
2.
Shimizu, Toshihiro, et al.. (2003). Formulation Study for Lansoprazole Fast-disintegrating Tablet. I.Effect of Compression on Dissolution Behavior. Chemical and Pharmaceutical Bulletin. 51(8). 942–947. 42 indexed citations
3.
Shimizu, Toshihiro, et al.. (2003). Formulation Study for Lansoprazole Fast-disintegrating Tablet. III. Design of Rapidly Disintegrating Tablets. Chemical and Pharmaceutical Bulletin. 51(10). 1121–1127. 51 indexed citations
4.
Shimizu, Toshihiro, et al.. (2003). Formulation Study for Lansoprazole Fast-disintegrating Tablet. II. Effect of Triethyl Citrate on the Quality of the Products. Chemical and Pharmaceutical Bulletin. 51(9). 1029–1035. 27 indexed citations
5.
6.
Igari, Yasutaka, et al.. (1996). In vitro release test system of (d,l-lactic-glycolic) acid copolymer microcapsules for sustained release of LHRH agonist (leuprorelin). Journal of Controlled Release. 40(3). 269–276. 15 indexed citations
7.
Igari, Yasutaka, et al.. (1993). Sustained release preparation of erythropoietin using sodium hyaluronate.. Drug Delivery System. 8(4). 237–241. 2 indexed citations
8.
Radominska, A, Jessica S Little, Jan St. Pyrek, et al.. (1993). A novel UDP-Glc-specific glucosyltransferase catalyzing the biosynthesis of 6-O-glucosides of bile acids in human liver microsomes. Journal of Biological Chemistry. 268(20). 15127–15135. 42 indexed citations
9.
Drake, Richard R., Yasutaka Igari, Roger Lester, Alan D. Elbein, & A Radominska. (1992). Application of 5-azido-UDP-glucose and 5-azido-UDP-glucuronic acid photoaffinity probes for the determination of the active site orientation of microsomal UDP-glucosyltransferases and UDP-glucuronosyltransferases.. Journal of Biological Chemistry. 267(16). 11360–11365. 38 indexed citations
10.
Iga, Katsumi, et al.. (1991). Increased Tumor Cisplatin Levels in Heated Tumors in Mice after Administration of Thermosensitive, Large Unilamellar Vesicles Encapsulating Cisplatin. Journal of Pharmaceutical Sciences. 80(6). 522–525. 23 indexed citations
11.
Iga, Katsumi, Yasutaka Igari, Yuriko Ogawa, et al.. (1991). Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia.. Journal of Pharmacology and Experimental Therapeutics. 257(3). 1203–1207. 31 indexed citations
12.
Iga, Katsumi, et al.. (1989). Heat-specific drug release of large unilamellar vesicle as hyperthermia-mediated targeting delivery. International Journal of Pharmaceutics. 57(3). 241–251. 23 indexed citations
13.
Okada, Hiroaki, Toshiro Heya, Yasutaka Igari, et al.. (1989). One-month release injectable microspheres of leuprolide acetate inhibit steroidogenesis and genital organ growth in rats. International Journal of Pharmaceutics. 54(3). 231–239. 60 indexed citations
14.
Igari, Yasutaka, Yuichi Sugiyama, Yasufumi Sawada, Tatsuji Iga, & M Hanano. (1985). Kinetics of receptor occupation and anticonvulsive effects of diazepam in rats.. Drug Metabolism and Disposition. 13(1). 102–106. 13 indexed citations
15.
Igari, Yasutaka, Yuichi Sugiyama, Yasufumi Sawada, Tatsuji Iga, & Manabu Hanano. (1984). In Vitro and In Vivo Assessment of Hepatic and Extrahepatic Metabolism of Diazepam in the Rat. Journal of Pharmaceutical Sciences. 73(6). 826–828. 25 indexed citations
16.
Igari, Yasutaka, Yuichi Sugiyama, Yasufumi Sawada, Tatsuji Iga, & Manabu Hanano. (1983). Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model. Journal of Pharmacokinetics and Biopharmaceutics. 11(6). 577–593. 88 indexed citations
17.
Igari, Yasutaka, Yuichi Sugiyama, Yasufumi Sawada, Tatsuji Iga, & M Hanano. (1982). Tissue distribution of 14C-diazepam and its metabolites in rats.. Drug Metabolism and Disposition. 10(6). 676–679. 36 indexed citations
18.
Igari, Yasutaka, Yuichi Sugiyama, Shoji Awazu, & Manabu Hanano. (1982). Comparative physiologically based pharmacokinetics of hexobarbital, phenobarbital, and thiopental in the rat. Journal of Pharmacokinetics and Biopharmaceutics. 10(1). 53–75. 72 indexed citations
19.
Igari, Yasutaka, Yuichi Sugiyama, Shoji Awazu, & Manabu Hanano. (1981). Interspecies Difference in Drug Protein Binding - Temperature and Protein Concentration Dependency: Effect on Calculation of Effective Protein Fraction. Journal of Pharmaceutical Sciences. 70(9). 1049–1053. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobutoshi Watari Breakdown of academic impact, for papers by Masayuki Akimoto Breakdown of academic impact, for papers by Guofei Li Breakdown of academic impact, for papers by Mark Wirth Breakdown of academic impact, for papers by Yutaka Higashi Breakdown of academic impact, for papers by Eleftheria Tsakalozou Breakdown of academic impact, for papers by Sumihisa Kimura Breakdown of academic impact, for papers by Yoshikazu Takeuchi Breakdown of academic impact, for papers by Graham Somers Breakdown of academic impact, for papers by B.D. Rush
Rankless by CCL
2026